BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 1117979)

  • 21. Acute effects of progesterone and the antiprogestin RU 486 on gonadotropin secretion in the follicular phase of the menstrual cycle.
    Permezel JM; Lenton EA; Roberts I; Cooke ID
    J Clin Endocrinol Metab; 1989 May; 68(5):960-5. PubMed ID: 2497130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma profile on pituitary gonadotropins and ovarian steroids in women during 17 alpha-acetoxy- 11 beta-methyl-19-nor-progesterone administration.
    Pérez-Palacios G; Iramain C; Castañeda E; Rojo B; Long DW; Scaglia HE; Gual C
    Contraception; 1975 Jul; 12(1):37-43. PubMed ID: 1139948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
    Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
    Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to intermittent RU486 in women.
    Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
    Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of follicle-stimulating hormone (FSH), in combination with luteinizing hormone (LH), in oestrogen-induced ovulation during the oestrous cycle in the rat.
    Plas-Roser S; Hassani M; Aron C
    Acta Endocrinol (Copenh); 1977 May; 85(1):151-7. PubMed ID: 577073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum follicle-stimulating hormone, luteinizing hormone and progesterone concentrations in pseudopregnant rats treated with medroxyprogesterone acetate.
    de Greef WJ; Dullaart J; Zeilmaker GH
    J Endocrinol; 1976 Sep; 70(3):465-71. PubMed ID: 978105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma concentrations of LH and of sex steroids during the normal menstrual cycle and during contraceptive treatment].
    Bayard F; Louvet JP; Moatti JP; Smilovici W; Duguet L; Boulard C
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):915-26. PubMed ID: 767402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 -oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones.
    Leyendecker G; Wardlaw S; Nocke W
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):160-78. PubMed ID: 4678011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
    Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
    J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women.
    Schaison G; George M; Lestrat N; Reinberg A; Baulieu EE
    J Clin Endocrinol Metab; 1985 Sep; 61(3):484-9. PubMed ID: 2991322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of ovulation induction.
    Wu CH
    Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
    Baird DT; McNeilly AS; Sawers RS; Sharpe RM
    J Clin Endocrinol Metab; 1979 Oct; 49(4):500-6. PubMed ID: 479342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ability of luteinizing hormone (LH) to acutely increase serum progesterone levels during the secretory phase of the rhesus menstrual cycle.
    Macdonald GJ; Greep RO
    Fertil Steril; 1972 Jul; 23(7):466-70. PubMed ID: 4624776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
    Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of Danazol as a contraceptive agent.
    Wentz AC; Jones GS; Sapp KC
    Contraception; 1976 May; 13(5):619-30. PubMed ID: 1261264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Examination of the role of FSH in periovulatory events in the hamster.
    Rani CS; Moudgal NR
    J Reprod Fertil; 1977 May; 50(1):37-45. PubMed ID: 864651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma hormone concentrations during the menstrual cycle of normal Chinese women.
    Salmon JA; Chew PC; Ratnam SS
    Acta Obstet Gynecol Scand; 1976; 55(3):239-43. PubMed ID: 936988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.